Skip to main content
. 2017 Jan 5;2(2):118–124. doi: 10.1016/j.adro.2016.12.005

Figure 3.

Figure 3

Histograms reporting the relative abundance of potential biomarkers in RPs and NRPs during chemoradiation therapy (CRT). Relative abundances of phosphatidylcholine (PC; 40:2), lysophosphatidylcholine (LPC;16:0/0:0), LPC (15:1 (9Z)/0:0), sphingomyelin (SM; d18:2/18:1), and lysophosphatidylethanolamine (LPE;22:5/0:0) are shown, respectively, before treatment (t0), during CRT (t14), and at the last therapy day (t28). See Fig 1 for abbreviations.